| BN/NHsdMcwi |
time to onset of heart contraction |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49.0 days-63.0 days |
23 |
|
931.69 |
s |
37.66 |
180.63 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
49377 |
461 |
| BN/NHsdMcwi |
left ventricular systolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
24 |
|
110.81 |
mmHg |
3.12 |
15.27 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
49965 |
461 |
| BN/NHsdMcwi |
time to peak heart contraction |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49.0 days-63.0 days |
24 |
|
1126.09 |
s |
23.27 |
113.99 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
50304 |
461 |
| BN/NHsdMcwi |
left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
18 |
|
69.33 |
mmHg |
6.38 |
27.05 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
47990 |
461 |
| BN/NHsdMcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
24 |
|
10.02 |
ml/min/g |
0.75 |
3.69 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
44795 |
461 |
| BN/NHsdMcwi |
left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
18 |
|
107.55 |
mmHg |
4.39 |
18.63 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
44894 |
461 |
| BN/NHsdMcwi |
heart contraction pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49.0 days-63.0 days |
17 |
|
43.0 |
mmHg |
2.61 |
10.78 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
48112 |
461 |
| BN/NHsdMcwi |
percent change in left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
17 |
post-ischemic value/pre-ischemic value x 100% |
48.94 |
% |
4.62 |
19.06 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
46397 |
461 |
| BN/NHsdMcwi |
heart rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49.0 days-63.0 days |
23 |
|
227.28 |
beats/min |
6.69 |
32.07 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
45226 |
461 |
| BN/NHsdMcwi |
left ventricular developed pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
24 |
|
71.06 |
mmHg |
3.3 |
16.17 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
45347 |
461 |
| BN/NHsdMcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
female |
49.0 days-63.0 days |
18 |
|
2.29 |
% |
0.69 |
2.95 |
digital scale post excision weight measurement |
|
|
Moms and pups used in studies were fed Teklad |
49475 |
461 |
| BN/NHsdMcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
male |
49.0 days-63.0 days |
17 |
|
3.12 |
% |
0.87 |
3.57 |
digital scale post excision weight measurement |
|
|
Moms and pups used in studies were fed Teklad |
49474 |
461 |
| BN/NHsdMcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
male |
49.0 days-63.0 days |
24 |
|
6.26 |
% |
2.01 |
9.87 |
digital scale post excision weight measurement |
|
|
Moms and pups used in studies were fed Teklad |
49775 |
461 |
| BN/NHsdMcwi |
time to onset of heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49.0 days-63.0 days |
19 |
|
899.05 |
s |
56.67 |
247.03 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
50197 |
461 |
| BN/NHsdMcwi |
left ventricular diastolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
21 |
|
32.91 |
mmHg |
2.72 |
12.45 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
46495 |
461 |
| BN/NHsdMcwi |
time to peak heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49.0 days-63.0 days |
19 |
|
1266.15 |
s |
29.58 |
128.92 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
46626 |
461 |
| BN/NHsdMcwi |
percent change in left ventricular systolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49.0 days-63.0 days |
22 |
post-ischemic value/pre-ischemic value x 100% |
76.24 |
% |
3.86 |
18.08 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
48834 |
461 |
| BN/NHsdMcwi |
percent change in left ventricular systolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49.0 days-63.0 days |
24 |
post-ischemic value/pre-ischemic value x 100% |
78.22 |
% |
1.72 |
8.45 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
48833 |
461 |
| BN/NHsdMcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49.0 days-63.0 days |
10 |
|
11.48 |
IU/g |
0.82 |
2.59 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
45710 |
461 |
| BN/NHsdMcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
23 |
post-ischemic value/pre-ischemic value x 100% |
55.18 |
% |
3.21 |
15.39 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
47154 |
461 |
| BN/NHsdMcwi |
percent change in left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
15 |
post-ischemic value/pre-ischemic value x 100% |
77.68 |
% |
6.75 |
26.15 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
44997 |
461 |
| BN/NHsdMcwi |
heart rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49.0 days-63.0 days |
24 |
|
222.91 |
beats/min |
8.17 |
40.04 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
45225 |
461 |
| BN/NHsdMcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49.0 days-63.0 days |
9 |
|
7.39 |
IU/g |
0.95 |
2.84 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
49846 |
461 |
| BN/NHsdMcwi |
heart contraction pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49.0 days-63.0 days |
23 |
|
33.83 |
mmHg |
1.95 |
9.36 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
50075 |
461 |
| BN/NHsdMcwi |
left ventricular diastolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
24 |
|
39.16 |
mmHg |
2.2 |
10.76 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
46494 |
461 |
| BN/NHsdMcwi |
time to peak heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49.0 days-63.0 days |
17 |
|
1122.01 |
s |
33.31 |
137.33 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
46627 |
461 |
| BN/NHsdMcwi |
left ventricular diastolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
18 |
|
38.91 |
mmHg |
3.02 |
12.83 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
47779 |
461 |
| BN/NHsdMcwi |
left ventricular diastolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
18 |
|
33.66 |
mmHg |
4.0 |
16.99 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
47780 |
461 |
| BN/NHsdMcwi |
left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
18 |
|
108.97 |
mmHg |
3.01 |
12.79 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
44893 |
461 |
| BN/NHsdMcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49.0 days-63.0 days |
3 |
|
34.51 |
IU/g |
7.7 |
13.34 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46012 |
461 |
| BN/NHsdMcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
18 |
post-ischemic value/pre-ischemic value x 100% |
54.05 |
% |
4.54 |
19.26 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46143 |
461 |
| BN/NHsdMcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
19 |
post-ischemic value/pre-ischemic value x 100% |
62.66 |
% |
5.0 |
21.81 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46144 |
461 |
| BN/NHsdMcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
18 |
|
8.39 |
ml/min/g |
0.75 |
3.2 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46279 |
461 |
| BN/NHsdMcwi |
percent change in left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
15 |
post-ischemic value/pre-ischemic value x 100% |
51.12 |
% |
7.76 |
30.06 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
46398 |
461 |
| BN/NHsdMcwi |
heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49.0 days-63.0 days |
18 |
|
225.77 |
beats/min |
11.59 |
49.17 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
49023 |
461 |
| BN/NHsdMcwi |
heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49.0 days-63.0 days |
18 |
|
211.19 |
beats/min |
11.12 |
47.16 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
49024 |
461 |
| BN/NHsdMcwi |
time to onset of heart contraction |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49.0 days-63.0 days |
24 |
|
875.85 |
s |
23.17 |
113.51 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
49376 |
461 |
| BN/NHsdMcwi |
heart contraction pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49.0 days-63.0 days |
24 |
|
43.88 |
mmHg |
2.21 |
10.82 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
50074 |
461 |
| BN/NHsdMcwi |
time to peak heart contraction |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49.0 days-63.0 days |
23 |
|
1201.4 |
s |
34.75 |
166.65 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
50305 |
461 |
| BN/NHsdMcwi |
left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
18 |
|
70.53 |
mmHg |
4.1 |
17.38 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
47989 |
461 |
| BN/NHsdMcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49.0 days-63.0 days |
4 |
|
40.49 |
IU/g |
5.92 |
11.84 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46011 |
461 |
| BN/NHsdMcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
21 |
post-ischemic value/pre-ischemic value x 100% |
57.27 |
% |
3.35 |
15.34 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
47155 |
461 |
| BN/NHsdMcwi |
heart contraction pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49.0 days-63.0 days |
19 |
|
42.11 |
mmHg |
2.6 |
11.31 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
48111 |
461 |
| BN/NHsdMcwi |
percent change in heart rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49.0 days-63.0 days |
23 |
post-ischemic value/pre-ischemic value x 100% |
86.83 |
% |
2.21 |
10.58 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
48373 |
461 |
| BN/NHsdMcwi |
percent change in heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49.0 days-63.0 days |
17 |
post-ischemic value/pre-ischemic value x 100% |
80.05 |
% |
5.86 |
24.15 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
48485 |
461 |
| BN/NHsdMcwi |
left ventricular developed pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
22 |
|
73.79 |
mmHg |
3.69 |
17.32 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
45348 |
461 |
| BN/NHsdMcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
female |
49.0 days-63.0 days |
23 |
|
4.31 |
% |
1.05 |
5.04 |
digital scale post excision weight measurement |
|
|
Moms and pups used in studies were fed Teklad |
49776 |
461 |
| BN/NHsdMcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49.0 days-63.0 days |
8 |
|
7.23 |
IU/g |
0.96 |
2.7 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
49847 |
461 |
| BN/NHsdMcwi |
left ventricular systolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
23 |
|
101.61 |
mmHg |
5.04 |
24.16 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
49966 |
461 |
| BN/NHsdMcwi |
time to onset of heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49.0 days-63.0 days |
17 |
|
867.1 |
s |
35.89 |
147.99 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
50198 |
461 |
| BN/NHsdMcwi |
percent change in left ventricular developed pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
22 |
post-ischemic value/pre-ischemic value x 100% |
55.29 |
% |
3.87 |
18.15 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
48605 |
461 |
| BN/NHsdMcwi |
percent change in left ventricular developed pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
22 |
post-ischemic value/pre-ischemic value x 100% |
52.63 |
% |
2.7 |
12.67 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
48604 |
461 |
| BN/NHsdMcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49.0 days-63.0 days |
10 |
|
9.69 |
IU/g |
0.76 |
2.4 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
45711 |
461 |
| BN/NHsdMcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
23 |
|
9.42 |
ml/min/g |
0.62 |
2.95 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
44796 |
461 |
| BN/NHsdMcwi |
percent change in left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
17 |
post-ischemic value/pre-ischemic value x 100% |
73.09 |
% |
5.15 |
21.23 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
44996 |
461 |
| BN/NHsdMcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
18 |
|
10.61 |
ml/min/g |
1.14 |
4.84 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46280 |
461 |
| BN/NHsdMcwi |
percent change in heart rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49.0 days-63.0 days |
24 |
post-ischemic value/pre-ischemic value x 100% |
94.79 |
% |
6.88 |
33.7 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
48372 |
461 |
| BN/NHsdMcwi |
percent change in heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49.0 days-63.0 days |
19 |
post-ischemic value/pre-ischemic value x 100% |
83.61 |
% |
6.45 |
28.14 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
48484 |
461 |